You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-CD105 antibody [SN6]See all CD105 primary antibodies ...
  • Description
    Mouse monoclonal [SN6] to CD105
  • Specificityab11414 recognises the human CD105 cell surface antigen.
  • Tested applicationsFlow Cyt, IHC-Fr, IP, WB, IHC-P, ICC/IF, IHC-FoFr more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Partially purified cell membrane antigens from fresh leukaemia cells. (Human).

  • General notesThis product should be stored undiluted. Should this product contain a precipitate we recommend microcentrifugation before use.

Properties

Applications

Our Abpromise guarantee covers the use of ab11414 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
Flow Cyt Flow Cyt: Use at an assay dependent dilution. Use 10ul of the neat dilution to label 106 cells in 100ul.
IHC-Fr IHC-Fr: Use at an assay dependent dilution.
IP IP: Use at an assay dependent dilution.
WB WB: Use at an assay dependent dilution. Predicted molecular weight: 75 kDa. CD105 is a glycoprotein homodimer of 95kD subunits.
IHC-P IHC-P: Use at an assay dependent dilution. PubMed: 21612554
ICC/IF ICC/IF: 1/1000.
IHC-FoFr IHC-FoFr: Use at an assay dependent concentration.

Target

  • FunctionMajor glycoprotein of vascular endothelium. May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors.
  • Tissue specificityEndoglin is restricted to endothelial cells in all tissues except bone marrow.
  • Involvement in diseaseDefects in ENG are the cause of hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300, 108010]; also known as Osler-Rendu-Weber syndrome 1 (ORW1). HHT1 is an autosomal dominant multisystemic vascular dysplasia, characterized by recurrent epistaxis, muco-cutaneous telangiectases, gastro-intestinal hemorrhage, and pulmonary (PAVM), cerebral (CAVM) and hepatic arteriovenous malformations; all secondary manifestations of the underlying vascular dysplasia. Although the first symptom of HHT1 in children is generally nose bleed, there is an important clinical heterogeneity.
  • Cellular localizationMembrane.
  • Target information above from: UniProt accession P17813 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      CD 105 antibodyCD105 antibodyCD105 antigen antibody
      EGLN_HUMAN antibodyEND antibodyEndoglin antibodyENG antibodyFLJ41744 antibodyHHT1 antibodyORW antibodyORW1 antibodyOsler Rendu Weber syndrome 1 antibodyRP11 228B15.2 antibodySN6 antibody
    see all

Anti-CD105 antibody [SN6] images

  • ab11414 staining CD105 in human KG1 cells by Flow Cytometry analysis.
  • ab11414 staining CD105 in Human breast tissue by Immunohistochemistry (Frozen sections). The sections were fixed in methanol prior to blocking with 10% serum for 5 minutes at 25°C. The primary antibody was diluted 1/200 and incubated with the sample for 1 hour. An HRP-conjugated goat anti-mouse polyclonal was used as the secondary antibody.
    Stains exclusively in the stroma - endothelium of the vessels - in human breast tissue. The image shows epithelial breast gland tissue surrounded by stroma.

    See Abreview

References for Anti-CD105 antibody [SN6] (ab11414)

This product has been referenced in:
  • Iqbal SA  et al. Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy. Stem Cells Dev 21:609-22 (2012). IHC-P ; Human . Read more (PubMed: 21612554) »
  • Shao Z  et al. Polycaprolactone electrospun mesh conjugated with an MSC affinity peptide for MSC homing in vivo. Biomaterials 33:3375-87 (2012). ICC/IF ; Human . Read more (PubMed: 22322196) »

See all 7 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Human Tissue sections (Brain)
Specification Brain
Fixative Formaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: High pH, Neutral, Low pH
Permeabilization Yes - 0.25% Triton
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 2.5% · Temperature: 25°C
Username

Verified customer

Submitted Nov 05 2012

Application Immunohistochemistry (Frozen sections)
Sample Human Tissue sections (Brain)
Specification Brain
Fixative Paraformaldehyde
Permeabilization No
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Oct 12 2012

Application Immunohistochemistry (PFA perfusion fixed frozen sections)
Sample Human Tissue sections (Brain)
Specification Brain
Fixative Paraformaldehyde
Antigen retrieval step None
Permeabilization Yes - 0.2% Triton
Blocking step Goat serum as blocking agent for 30 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Oct 02 2012

Application Immunocytochemistry/ Immunofluorescence
Sample Horse Cell (Adipose and bone marrow stem cells)
Specification Adipose and bone marrow stem cells
Fixative Paraformaldehyde
Permeabilization Yes - TRITON x100 0,1%
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 10% · Temperature: 37°C
Username

Verified customer

Submitted Mar 29 2012

Application Immunohistochemistry (Frozen sections)
Sample Human Tissue sections (Human breast)
Specification Human breast
Fixative Methanol
Permeabilization No
Blocking step Serum as blocking agent for 5 minute(s) · Concentration: 10% · Temperature: 25°C
Username

Verified customer

Submitted Sep 23 2011

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"